Global /China /Healthcare /Drug Manufacturers - General /002898

Sailong Pharmaceutical Group Co.,Ltd.

002898

• SHE: 002898 • Delayed

8.30CNY -5%

1.23 USD

As of 15 June 2026, Sailong Pharmaceutical Group Co.,Ltd. has a market cap of $227.01M USD, ranking #20291 globally and #5697 in China. It ranks #1820 in the Healthcare sector, and #660 in the Drug Manufacturers - General industry.

Global Rank

20291

Country Rank

5697

Sector Rank

1820

Industry Rank

660

Key Stats

Market Cap

$227.01MUSD

1.54B CNY

Enterprise Value

$240.13MUSD

1.63B CNY

Revenue (TTM)

$36.13MUSD

244.84M CNY

EBITDA (TTM)

-$2.89MUSD

-19.54M CNY

Net Income (TTM)

-$10.31MUSD

-69.85M CNY

EBITDA Margin

-8%

Profit Margin

-29%

PS Ratio

6.3

PB Ratio

3.3

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Nan Gui Cai open_in_new

Employees

514

Founded

2002

Website

sailong.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-5%	-23%	-24%	-31%	-38%	-36%	44%	-20%	-13%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	002898 珠海赛隆药业股份有限公司 Class A ISIN: CNE1000032S5 Shares Out.: Shares Outstanding: 176.0M¹ Shares Float: 151.049M² TV: TradingView: SZSE: 002898 SA: Stock Analysis: SHE: 002898 YF: Yahoo Finance: 002898.SZ GF: Google Finance: SHE: 002898 BA: Barron's: 002898 MS: Morningstar: XSHE: 002898	8.30 CNY	TV: TradingView: SZSE: 002898 SA: Stock Analysis: SHE: 002898 YF: Yahoo Finance: 002898.SZ GF: Google Finance: SHE: 002898 BA: Barron's: 002898 MS: Morningstar: XSHE: 002898

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Sailong Pharmaceutical Group Co.,Ltd.

Sailong Pharmaceutical Group Co.,Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China. The company offers esomeprazole sodium, ornithine aspartate, thymus, argatroban, tigecycline, monosialotetrahexose ganglioside sodium, cerebroprotein hydrolysate, milrinone, parecoxib sodium, tranexamic acid, clindamycin phosphate, pantoprazole sodium products, etc. It provides its products for therapeutic areas, such as cardiovascular, cerebrovascular, nerve, digestive system, proton pump inhibitors, anti-infectives, anti-bleeding drugs, analgesics, and other fields. Sailong Pharmaceutical Group Co.,Ltd. was formerly known as Zhuhai Sailong Pharmaceutical Co.,Ltd. and changed its name to Sailong Pharmaceutical Group Co.,Ltd. in September 2021. The company was founded in 2002 and is based in Zhuhai, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.85B 364.89B CNY 24K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.64B 336.36B CNY 22K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 12K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 8K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.51B 111.89B CNY 7K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 7K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 335K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 241K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 159K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 142K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 127K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 121K%	20.5	Switzerland

chevron_leftBack